Point of Care Molecular Diagnostics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
Global Point of Care Molecular Diagnostics Market
Research and Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Point of Care Molecular Diagnostics
  Market Global Industry Trends, Share, Size,
  Growth, Opportunity and Forecast
  2024-2032," the global point of care molecular
  diagnostics market size reached US 3.7 Billion
  in 2023.
• Point of care (POC) molecular diagnostics is an
  approach in medical testing and diagnostics. It
  comprises a range of innovative techniques and
  technologies that are designed to provide rapid
  and accurate analysis of biological samples, such
  as blood, urine, or tissue, at the bedside of the
  patient or within proximity to the healthcare
  provider.
• It offers real-time and on-site testing that
  enables enhanced decision-making in clinical
  settings. It assists in detecting specific
  genetic material, such as deoxyribonucleic acid
  (DNA) or ribonucleic acid (RNA), within patient
  samples. As it allows for the identification of
  pathogens, genetic mutations, or disease markers
  at an early stage, the demand for POC molecular
  diagnostics is rising worldwide.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/point-of-care-molecular
  -diagnostics-market/requestsample

4
Report Description

• Global Point of Care Molecular Diagnostics Market
  Trends
• At present, the increasing need for rapid and
  precise medical information to enhance patient
  care outcomes represents one of the primary
  factors contributing to the growth of the market.
  Besides this, the rising demand for POC molecular
  diagnostics, as it offers high accuracy, is
  strengthening the market growth.
• Moreover, the increasing development of
  user-friendly and portable devices and assays for
  enhanced convenience is bolstering the growth of
  the market. Apart from this, the rising focus on
  personalized medicine is propelling the growth of
  the market.
• Looking forward, the market value is projected to
  reach US 8.4 Billion by 2032, expanding at a
  CAGR of 9.2 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/point-of-care-molecular
  -diagnostics-market

5
Report Segmentation

• Breakup by Product and Service
• Assays and Kits
• Instruments and Analyzers
• Software and Services
•  
• Breakup by Technology
• Polymerase Chain Reaction (PCR)
• Hybridization
• DNA sequencing
• Microarray
• Isothermal Nucleic Acid Amplification Technology
  (INAAT)
• Others
• Breakup by Application
• Infectious Diseases
• Oncology
• Hematology

6
Report Segmentation

• Prenatal Testing
• Endocrinology
• Others
• Breakup by End User
• Physicians Offices
• Hospitals and ICUs
• Research Institutes
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Abbott Laboratories
• Becton Dickinson and Company
• Binx Health Inc.
• Co-Diagnostics Inc.
• F. Hoffmann-La Roche Ltd
• Gene STAT Molecular Diagnostics LLC
• Hemocue AB (Danaher Corporation)
• Meridian Bioscience Inc.
• Molbio Diagnostics Private Limited
• Quidel Corporation
• Siemens Healthcare GmbH (Siemens AG)
• Thermo Fisher Scientific Inc.
• Visby Medical Inc.

8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Point of Care
  Molecular Diagnostics Market    5.1    Market
  Overview    5.2    Market Performance    5.3  
   Impact of COVID-19  5.4    Market Forecast
• 6     Market Breakup by Product and Service   
  6.1    Assays and kits        6.1.1 Market
  Trends        6.1.2 Market Forecast    6.2  
   Instruments and Analyzers        6.2.1 Market
  Trends        6.2.2 Market Forecast    6.3  
   Software and Services        6.3.1 Market
  Trends        6.3.2 Market Forecast7    Market
  Breakup by Technology       

10
Table of Contents

•     7.1    Polymerase Chain Reaction (PCR)     
    7.1.1 Market Trends        7.1.2 Market
  Forecast    7.2    Hybridization        7.2.1
  Market Trends        7.2.2 Market Forecast   
  7.3    DNA sequencing        7.3.1 Market
  Trends        7.3.2 Market Forecast    7.4  
   Microarray        7.4.1 Market Trends       
  7.4.2 Market Forecast    7.5    Isothermal
  Nucleic Acid Amplification Technology (INAAT)   
      7.5.1 Market Trends        7.5.2 Market
  Forecast    7.6    Others        7.6.1 Market
  Trends        7.6.2 Market Forecast8    Market
  Breakup by Application    8.1    Infectious
  Diseases        8.1.1 Market Trends       
  8.1.2 Market Forecast    8.2    Oncology       
  8.2.1 Market Trends        8.2.2 Market Forecast
•     8.3    Hematology        8.3.1 Market
  Trends        8.3.2 Market Forecast
• For more information, visit https//www.imarcgrou
  p.com/point-of-care-molecular-diagnostics-market/t
  oc

11
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com